FDMT

FDMT EBITDA Margin

-199.94%TTM

Period ending:

FDMT FY EBITDA Margin%
FDMT FY EBITDA Margin49921.91%-466647.33%
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

FDMT ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

4D Molecular Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-155.4812%
-416,656.7568%
-458.8525%
-3,311.4094%
-378.6285%
-405.6788%
-638.7489%
-68.6624%
-183.8687%

Compare ebitda margin

All FDMT financial metrics · FDMT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.